EcoDrugPlus

Insulin Receptor-Like

Ensembl ID : ENSHCOG00000002618
Gene Symbol: LOC109507385
3 Cross references
213 Possible Orthologues:

Insulin-Like Growth Factor 1 Receptor

Ensembl ID : ENSHCOG00000004460
Gene Symbol: LOC109513166
3 Cross references
205 Possible Orthologues:

Integrin Alpha-5-Like

Ensembl ID : ENSHCOG00000007331
Gene Symbol: LOC109513781
3 Cross references
206 Possible Orthologues:

Integrin Beta-1-Like

Ensembl ID : ENSHCOG00000004592
Gene Symbol: LOC109517002
3 Cross references
213 Possible Orthologues:

Integrin Beta-3-Like

Ensembl ID : ENSHCOG00000005913
Gene Symbol: LOC109532691
3 Cross references
201 Possible Orthologues:

Integrin Subunit Alpha 4

Ensembl ID : ENSHCOG00000003896
Gene Symbol: ITGA4
3 Cross references
225 Possible Orthologues:

Integrin Subunit Alpha 5

Ensembl ID : ENSHCOG00000013641
Gene Symbol: ITGA5
3 Cross references
197 Possible Orthologues:

Integrin Subunit Alpha V

Ensembl ID : ENSHCOG00000000447
Gene Symbol: ITGAV
3 Cross references
237 Possible Orthologues:

Integrin Subunit Beta 1

Ensembl ID : ENSHCOG00000011595
Gene Symbol: ITGB1
4 Cross references
228 Possible Orthologues:

Integrin Subunit Beta 1

Ensembl ID : ENSHCOG00000011563
Gene Symbol: ITGB1
4 Cross references
228 Possible Orthologues:

Integrin Subunit Beta 5

Ensembl ID : ENSHCOG00000015991
Gene Symbol: ITGB5
3 Cross references
204 Possible Orthologues:

Integrin Subunit Beta 6

Ensembl ID : ENSHCOG00000020068
Gene Symbol: ITGB6
3 Cross references
205 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).